Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil.
作者信息
Seque C A, Enokihara M M S S, Nascimento M M, Porro A M, Tomimori J
机构信息
Dermatology Department, Federal University of Sao Paulo, Sao Paulo, Brazil.
Programa de Pós graduação em Medicina Translacional, Federal University of São Paulo, Sao Paulo, Brazil.
出版信息
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e601-e603. doi: 10.1111/jdv.18112. Epub 2022 Apr 12.
Abstract
摘要
相似文献
1
Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil.
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e601-e603. doi: 10.1111/jdv.18112. Epub 2022 Apr 12.
2
In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
Ann Intern Med. 2021 Mar;174(3):JC29. doi: 10.7326/ACPJ202103160-029. Epub 2021 Mar 2.
3
Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?
Vaccines (Basel). 2022 Apr 13;10(4):602. doi: 10.3390/vaccines10040602.
4
Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 Vaccinated Individuals.
Arch Med Res. 2022 Jun;53(4):341-351. doi: 10.1016/j.arcmed.2022.03.008. Epub 2022 May 6.
5
Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.
Dermatol Ther. 2021 Nov;34(6):e15146. doi: 10.1111/dth.15146. Epub 2021 Oct 7.
6
Limb ischemia and pulmonary artery thrombosis after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune thrombotic thrombocytopenia.
CMAJ. 2021 Jun 14;193(24):E906-E910. doi: 10.1503/cmaj.210795. Epub 2021 May 14.
7
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.
Vaccines (Basel). 2021 Nov 15;9(11):1326. doi: 10.3390/vaccines9111326.
8
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.
J Hepatol. 2021 Nov;75(5):1249-1250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22.
9
Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
Dan Med J. 2021 Mar 31;68(5):A03210292.
10
Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.
Front Public Health. 2022 Jul 19;10:937794. doi: 10.3389/fpubh.2022.937794. eCollection 2022.
引用本文的文献
1
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.
NPJ Vaccines. 2024 Jun 5;9(1):99. doi: 10.1038/s41541-024-00895-z.
2
Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman.
Oman Med J. 2023 Nov 30;38(6):e579. doi: 10.5001/omj.2024.01. eCollection 2023 Nov.
本文引用的文献
1
A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination.
J Dermatol. 2022 Mar;49(3):e117-e118. doi: 10.1111/1346-8138.16257. Epub 2021 Nov 25.
2
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2.
3
Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.
Dermatol Ther. 2021 Nov;34(6):e15153. doi: 10.1111/dth.15153. Epub 2021 Oct 13.
4
Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.
Clin Exp Dermatol. 2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10.
5
Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2.
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e741-e743. doi: 10.1111/jdv.17547. Epub 2021 Aug 4.
6
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
Br J Dermatol. 2022 Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21.
7
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
8
Lichen planus arising after COVID-19 vaccination.
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e414-e415. doi: 10.1111/jdv.17221. Epub 2021 Mar 28.
9
Annular lichen planus associated with coronavirus SARS-CoV-2 disease (COVID-19).
Int J Dermatol. 2021 Feb;60(2):246-247. doi: 10.1111/ijd.15338. Epub 2020 Dec 15.
Zotero 插件